biomarker discovery
BostonGene to Support LegoChem Biosciences Clinical Trial of TROP2-Directed Cancer Therapy
BostonGene will provide comprehensive molecular analysis services as part of the pharma firm's multicenter study of the novel therapy.
Engine Biosciences Extends Series A Financing Round by $27M
The Singapore-based biomarker discovery firm has now raised at least $86 million to date, including $70 million in its Series A financing.
Caris Life Sciences Partners with Moderna to Help Develop mRNA-Based Cancer Therapeutics
The multiyear partnership gives Moderna access to Caris' library of multimodal clinico-genomic data for its oncology R&D pipeline.
Genialis, Cancer Research Horizons Partner to Predict Drug Responses
CRH will provide colorectal cancer datasets of diverse patient populations that Genialis will use to improve and validate its ResponderID platform.
BostonGene, Hokkaido University to Study Biomarkers of Response in HER2-Positive Breast Cancer
The collaborators aim to use BostonGene's algorithms and genomics tools to identify HER2-positive breast cancer patients likely to respond to certain therapies.
Sep 18, 2023